MedTrace Logo

Determination of the "Tissue Transit Time" (TTT)

NCT03311256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2022-05-09

No results posted yet for this study

Summary

Determination of Tissue Transit Time (TTT) as a parameter with high prognostic value to predict the functional course of the differential renal function and the development of the differential renal function after pyeloplasty

Conditions

  • Renal Insufficiency, Acute

Interventions

DIAGNOSTIC_TEST

Tissue Transit Time

Determination of Tissue Transit Time as a prognostic and diagnostic factor

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Tobias Luithle, MD · Universtiätsklinikum Tübingen

Eligibility

Max Age
3 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-23
Primary Completion
2021-06-30
Completion
2021-11-24

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03311256 on ClinicalTrials.gov